FDA’s Upcoming PTSD Meeting; Ketamine Catch-22; ‘Lifestyle Psychiatry’ Trending

The FDA is holding a meeting next week on advancing treatments for post-traumatic stress disorder.

Female doctors have an increased risk for suicide compared with their counterparts in the general population, a 20-country meta-analysis found. (The BMJ)

The Atlantic examined the catch-22 that is ketamine.

In a phase II dose-finding study of adults with schizophrenia, the lowest dose of an investigational muscarinic M4 selective agonist significantly reduced scores on the Positive and Negative Syndrome Scale versus placebo, Neurocrine Biosciences said.

ProPublica did a deep dive into state mental health laws.

Kentucky is unnecessarily housing patients with serious mental illness in psychiatric hospitals and violating the Americans with Disabilities Act in doing so, the Justice Department alleged.

While investigational xanamem failed to meet its primary goal in a placebo-controlled phase IIa trial of patients with cognitive dysfunction and major depressive disorder, developer Actinogen Medical said the drug showed significant benefit for the secondary outcome of depression scores in the subgroup with baseline cognitive impairment.

Lifestyle psychiatry is trending — but what is it? (Forbes)

Inflammatory biomarkers — including leukocytes, haptoglobin, C-reactive protein, and immunoglobulin G — were linked with a heightened risk of developing psychiatric disorders, a cohort study indicated. (JAMA Psychiatry)

The Surgeon General issued an advisory urging more support for the mental health and well-being of parents and caregivers.

More than 500 therapists told ProPublica about the myriad of factors that led them to go out-of-network.

Epic Research data found that older adults with diabetes diagnosed with Alzheimer’s disease were more likely to have average HbA1c values under 6.5% or over 8% in the 5 years prior to the diagnosis compared with diabetic patients without Alzheimer’s.

Rep. Yadira Caraveo, MD (D-Colo.), said she had sought treatment for depression and is speaking out in order to help destigmatize mental illness. (NBC News)